Sarepta Therapeutics Inc (SRPT)
160.73
+37.17
(+30.08%)
USD |
NASDAQ |
Jun 21, 16:00
160.72
-0.01
(-0.01%)
After-Hours: 16:16
Sarepta Therapeutics Accounts Receivable (Quarterly): 378.81M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 378.81M |
December 31, 2023 | 400.33M |
September 30, 2023 | 318.86M |
June 30, 2023 | 236.81M |
March 31, 2023 | 223.84M |
December 31, 2022 | 214.63M |
September 30, 2022 | 201.51M |
June 30, 2022 | 203.85M |
March 31, 2022 | 178.19M |
December 31, 2021 | 152.99M |
September 30, 2021 | 149.32M |
June 30, 2021 | 127.05M |
March 31, 2021 | 117.73M |
December 31, 2020 | 100.87M |
September 30, 2020 | 104.49M |
June 30, 2020 | 94.69M |
March 31, 2020 | 89.96M |
December 31, 2019 | 90.41M |
September 30, 2019 | 67.26M |
June 30, 2019 | 56.19M |
March 31, 2019 | 49.72M |
December 31, 2018 | 48.25M |
September 30, 2018 | 47.81M |
June 30, 2018 | 42.06M |
March 31, 2018 | 38.92M |
Date | Value |
---|---|
December 31, 2017 | 28.54M |
September 30, 2017 | 24.75M |
June 30, 2017 | 17.79M |
March 31, 2017 | 12.28M |
December 31, 2016 | 5.228M |
September 30, 2016 | 3.986M |
June 30, 2016 | 3.982M |
March 31, 2016 | 3.99M |
December 31, 2015 | 3.977M |
September 30, 2015 | 2.733M |
June 30, 2015 | 2.416M |
March 31, 2015 | 2.416M |
December 31, 2014 | 2.416M |
September 30, 2014 | 3.362M |
June 30, 2014 | 5.226M |
March 31, 2014 | 7.849M |
December 31, 2013 | 3.53M |
September 30, 2013 | 6.721M |
June 30, 2013 | 3.788M |
March 31, 2013 | 5.652M |
December 31, 2012 | 4.713M |
September 30, 2012 | 2.474M |
June 30, 2012 | 7.18M |
March 31, 2012 | 5.135M |
December 31, 2011 | 3.633M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
56.19M
Minimum
Jun 2019
400.33M
Maximum
Dec 2023
175.39M
Average
151.15M
Median
Accounts Receivable (Quarterly) Benchmarks
Pfizer Inc | 10.99B |
Johnson & Johnson | 14.95B |
PTC Therapeutics Inc | 197.66M |
Catalyst Pharmaceuticals Inc | 60.49M |
Vertex Pharmaceuticals Inc | 1.793B |